Kriya is advancing a host of gene therapies for a wide variety of chronic diseases, including geographic atrophy, trigeminal neuralgia and type 1 diabetes.
UF startup Kriya Therapeutics has raised $313.3 million in a funding round that the North Carolina–based gene therapy maker disclosed Friday in an SEC filing.
The regulatory document did not specify what the funds will be used for, nor did it identify the sources of the funding, only stating that two investors participated in the financing push. Friday’s haul adds to a $100 million series B raise in July 2021, a $270 million series C round in May 2022, which it extended by $150 million in July 2023.
Read more about Gene Therapy Specialist Kriya Raises $313M.
